Techsol specializes in delivering innovative scientific solutions for clinical drug discovery and development using a powerful combination of modern technology and data-driven insights. As a ‘Tech-enabled Scientific Solutions Provider’ (TSPO), we relentlessly work towards optimizing ‘Science’ with ‘Technology’ through constant knowledge expansion, continuous innovation, and identifying value diversification opportunities.

With the mission of optimizing medical research, developing novel treatments, and facilitating patient-centric care delivery, we partner with sponsors to deliver maximum value with uncompromised quality across the pharmaceutical product lifecycle.

Techsol Corporation Scientific Solutions Company

How We Deliver Technology Driven Scientific Process Solutions & Data Services

PV discussion

As a TSPO, we seek to partner with sponsor companies to accelerate the development of drugs and devices across various therapeutic areas using our scientific expertise, quality focused processes and proprietary technology innovation.

All our end-to-end clinical development, pharmacovigilance, and ancillary post-marketing scientific services are delivered using regulatory compliant GxP technology that enhances process quality, operational efficiency, and reduces time to completion. We primarily focus on delivering services in the following segments.

Why Biopharma and Medical Device Companies Prefer Us as their Extended Technology Partner

Coding in Computer

For over 11 years, our team has successfully delivered over 170+ enterprise level Life sciences IT Projects across different verticals. We are a leading GxP Technology Solutions Provider because of our proven capabilities in strategic consulting, technology selection, system implementation, computer systems validation, system integration, reports and analytics and application support.

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Let Us Know How We Can Help You